NOS3 polymorphisms are associated with arterial stiffness in children with type 1 diabetes

Issam Zineh1, Amber L Beitelshees, Michael J Haller

  • 1Department of Pharmacy Practice and Center for Pharmacogenomics, University of Florida College of Pharmacy, Gainesville, Florida, USA.

Diabetes Care
|March 1, 2007
PubMed

Insights

Genetic variations in the NOS3 gene are linked to arterial stiffness in children with type 1 diabetes. The -786T-->C polymorphism showed a significant association, suggesting a potential role in cardiovascular risk assessment.

Area of Science:

  • Cardiovascular Research
  • Genetics
  • Pediatric Endocrinology

Background:

  • Type 1 diabetes (T1D) is linked to endothelial dysfunction, arterial stiffness, and increased cardiovascular disease (CVD) risk.
  • Previous studies showed increased arterial stiffness in children with T1D, unexplained by traditional CVD risk factors.
  • Significant variation in arterial stiffness exists within pediatric T1D populations.

Purpose of the Study:

  • To investigate the association between NOS3 gene polymorphisms and arterial stiffness in children with T1D.
  • To explore potential genetic contributors to the variability of arterial stiffness observed in this population.

Main Methods:

  • Studied 36 children (aged 10-21) with T1D undergoing radial tonometry.
  • Measured arterial stiffness using corrected augmentation index (AI75).
  • Determined genotypes for NOS3 -786T-->C and Glu298-->Asp polymorphisms via pyrosequencing; compared AI75 values by genotype using ANOVA and multivariate analysis.

Main Results:

  • A significant difference in AI75 was found between -786TT and -786C carriers (P=0.01).
  • No significant difference in AI75 was observed between Glu298Glu and Asp298 carriers (P=0.59).
  • Univariate analysis identified age, sex, BMI percentile, and the -786T-->C genotype as significantly associated with AI75. A multivariate model including these factors was also significant (P=0.002, R2=0.40).

Conclusions:

  • This study reports the first association between the NOS3 -786T-->C polymorphism and arterial stiffness in pediatric type 1 diabetes.
  • These findings suggest a potential genetic influence on arterial stiffness in T1D.
  • Larger studies are warranted to confirm these results for potential application in CVD risk assessment.
Abstract

Related Concept Videos

Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...